Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Somberg

Showing results (51-60 of 135) with videos related to

Pageof 14
Sort By:
Journal of Clinical Pharmacology|October 1, 1985
Digitalis: neurally mediated arrhythmogenic and coronary vasoconstrictor propertiesJ C Somberg
Journal of Clinical Pharmacology|August 1, 1991
A milestone in clinical pharmacologyJ C Somberg
Journal of Clinical Pharmacology|February 1, 1991
Drug classification and actionsJ C Somberg
American Journal of Therapeutics|April 24, 2001
Is the evidence right in evidence-based practice?J C Somberg
American Journal of Therapeutics|April 17, 2001
Sudden death in athletesJ C Somberg
The American Journal of Cardiology|August 13, 1984
New directions in antiarrhythmic drug therapyJ C Somberg
Journal of Clinical Pharmacology|August 1, 1990
The drug development process and clinical practiceJ C Somberg
Journal of Clinical Pharmacology|July 1, 1990
The Food and Drug Administration CommissionerJ C Somberg
Journal of Clinical Pharmacology|February 1, 1990
Non-approved indicationsJ C Somberg
The American Journal of Cardiology|August 13, 1984
New directions in antiarrhythmic drug therapy: the development of a promising new agent, lorcainideJ C Somberg, V Torres
Pageof 14

Showing results (51-60 of 135) with videos related to

Sort By:
Pageof 14
Journal of Clinical Pharmacology|October 1, 1985
Digitalis: neurally mediated arrhythmogenic and coronary vasoconstrictor propertiesJ C Somberg
Journal of Clinical Pharmacology|August 1, 1991
A milestone in clinical pharmacologyJ C Somberg
Journal of Clinical Pharmacology|February 1, 1991
Drug classification and actionsJ C Somberg
American Journal of Therapeutics|April 24, 2001
Is the evidence right in evidence-based practice?J C Somberg
American Journal of Therapeutics|April 17, 2001
Sudden death in athletesJ C Somberg
The American Journal of Cardiology|August 13, 1984
New directions in antiarrhythmic drug therapyJ C Somberg
Journal of Clinical Pharmacology|August 1, 1990
The drug development process and clinical practiceJ C Somberg
Journal of Clinical Pharmacology|July 1, 1990
The Food and Drug Administration CommissionerJ C Somberg
Journal of Clinical Pharmacology|February 1, 1990
Non-approved indicationsJ C Somberg
The American Journal of Cardiology|August 13, 1984
New directions in antiarrhythmic drug therapy: the development of a promising new agent, lorcainideJ C Somberg, V Torres
Pageof 14